152 related articles for article (PubMed ID: 12135941)
1. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis.
Franceschi F; Sepulveda AR; Gasbarrini A; Pola P; Silveri NG; Gasbarrini G; Graham DY; Genta RM
Circulation; 2002 Jul; 106(4):430-4. PubMed ID: 12135941
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
3. Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori.
Niccoli G; Franceschi F; Cosentino N; Giupponi B; De Marco G; Merra G; Conte M; Montone RA; Ferrante G; Bacà M; Gasbarrini A; Silveri NG; Crea F
Coron Artery Dis; 2010 Jun; 21(4):217-21. PubMed ID: 20389238
[TBL] [Abstract][Full Text] [Related]
4. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease.
Rožanković PB; Huzjan AL; Cupić H; Benčić IJ; Bašić S; Demarin V
J Neurol; 2011 May; 258(5):753-61. PubMed ID: 21085982
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study.
Mayr M; Kiechl S; Mendall MA; Willeit J; Wick G; Xu Q
Stroke; 2003 Mar; 34(3):610-5. PubMed ID: 12624280
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide.
Figura N; Palazzuoli A; Vaira D; Campagna M; Moretti E; Iacoponi F; Giordano N; Clemente S; Nuti R; Ponzetto A
J Clin Pathol; 2014 Mar; 67(3):251-7. PubMed ID: 24334757
[TBL] [Abstract][Full Text] [Related]
7. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases.
Franceschi F; Niccoli G; Ferrante G; Gasbarrini A; Baldi A; Candelli M; Feroce F; Saulnier N; Conte M; Roccarina D; Lanza GA; Gasbarrini G; Gentiloni SN; Crea F
Atherosclerosis; 2009 Feb; 202(2):535-42. PubMed ID: 18599062
[TBL] [Abstract][Full Text] [Related]
8. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders.
Figura N; Di Cairano G; Lorè F; Guarino E; Gragnoli A; Cataldo D; Giannace R; Vaira D; Bianciardi L; Kristodhullu S; Lenzi C; Torricelli V; Orlandini G; Gennari C
J Physiol Pharmacol; 1999 Dec; 50(5):817-26. PubMed ID: 10695561
[TBL] [Abstract][Full Text] [Related]
9. H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease.
Lenzi C; Palazzuoli A; Giordano N; Alegente G; Gonnelli C; Campagna MS; Santucci A; Sozzi M; Papakostas P; Rollo F; Nuti R; Figura N
World J Gastroenterol; 2006 Dec; 12(48):7815-20. PubMed ID: 17203526
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxin-associated gene-A--positive Helicobacter pylori strains are associated with atherosclerotic stroke.
Pietroiusti A; Diomedi M; Silvestrini M; Cupini LM; Luzzi I; Gomez-Miguel MJ; Bergamaschi A; Magrini A; Carrabs T; Vellini M; Galante A
Circulation; 2002 Jul; 106(5):580-4. PubMed ID: 12147540
[TBL] [Abstract][Full Text] [Related]
11. [Helicobacter pylori CagA antigen antibodies].
Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
[TBL] [Abstract][Full Text] [Related]
12. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
[TBL] [Abstract][Full Text] [Related]
13. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
14. Association of CagA+ Helicobacter pylori infection with aortic atheroma.
Shmuely H; Passaro DJ; Vaturi M; Sagie A; Pitlik S; Samra Z; Niv Y; Koren R; Harell D; Yahav J
Atherosclerosis; 2005 Mar; 179(1):127-32. PubMed ID: 15721018
[TBL] [Abstract][Full Text] [Related]
15. CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke.
Diomedi M; Pietroiusti A; Silvestrini M; Rizzato B; Cupini LM; Ferrante F; Magrini A; Bergamaschi A; Galante A; Bernardi G
Neurology; 2004 Sep; 63(5):800-4. PubMed ID: 15365126
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains.
Lind J; Backert S; Hoffmann R; Eichler J; Yamaoka Y; Perez-Perez GI; Torres J; Sticht H; Tegtmeyer N
BMC Microbiol; 2016 Sep; 16(1):201. PubMed ID: 27590005
[TBL] [Abstract][Full Text] [Related]
17. The pattern of CagA and VacA proteins in Helicobacter pylori seropositive asymptomatic children in western Saudi Arabia.
Jaber SM
Saudi Med J; 2005 Sep; 26(9):1372-7. PubMed ID: 16155650
[TBL] [Abstract][Full Text] [Related]
18. Gastroduodenal Helicobacter pylori infection diagnosed by Helicobacter pylori stool antigen is related to atherosclerosis.
Adiloglu AK; Nazli C; Cicioglu-Aridogan B; Kinay O; Can R; Ergene O
Acta Cardiol; 2003 Aug; 58(4):335-9. PubMed ID: 12948039
[TBL] [Abstract][Full Text] [Related]
19. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke.
Gabrielli M; Santoliquido A; Cremonini F; Cicconi V; Candelli M; Serricchio M; Tondi P; Pola R; Gasbarrini G; Pola P; Gasbarrini A
Eur Heart J; 2004 Jan; 25(1):64-8. PubMed ID: 14683744
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori anti-CagA antibodies: prevalence in symptomatic and asymptomatic subjects in Turkey.
Abasiyanik MF; Sander E; Salih BA
Can J Gastroenterol; 2002 Aug; 16(8):527-32. PubMed ID: 12226680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
